Patterns of disease activity in systemic lupus erythematosus.

OBJECTIVE To describe patterns of systemic lupus (SLE) disease activity over time. METHODS Disease activity was measured in a prospective cohort of 204 consecutive SLE patients followed up quarterly for 2.0-7.5 years (911 person-years of followup). Physician's global assessment (PGA) and modified SLE Disease Activity Index (M-SLEDAI; omitting serology) scores were plotted against time for each patient. Definitions for disease activity patterns were developed by consensus using these plots, and the proportion of total follow-up time represented by each pattern was calculated. RESULTS Three patterns of SLE activity were apparent: relapsing-remitting (RR), chronic active (CA), and long quiescent (LQ). The CA pattern was the most frequent for both the PGA and M-SLEDAI, representing 58% and 40% of total person-years, respectively. The least common pattern was LQ (PGA 16%, M-SLEDAI 25%), while the RR pattern was intermediate in frequency (PGA 26%, M-SLEDAI 35%). Average disease activity during RR periods tended to be mild, while that during CA periods was more likely to be moderately severe. The most common discrepancy between instruments was that the PGA depicted CA when the M-SLEDAI showed an RR pattern. The M-SLEDAI did not appear to capture mild degrees of activity. CONCLUSION SLE activity was readily classified into 1 of 3 patterns: RR, CA, or LQ. The CA pattern was most common, suggesting that significant morbidity may arise from persistent disease activity. These findings may have important implications regarding the choice of outcome measures in SLE clinical trials, since comparison of flare rates may not account for chronic disease activity.

[1]  J. Nossent,et al.  SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. , 1998, The Journal of rheumatology.

[2]  D. Alarcón-Segovia,et al.  Remission of Systemic Lupus Erythematosus , 1996 .

[3]  D. Symmons,et al.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[4]  D. Gladman,et al.  Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares. , 1994, The Journal of rheumatology.

[5]  S. Bombardieri,et al.  Activity criteria in systemic lupus erythematosus. , 1994, Clinical and experimental rheumatology.

[6]  C. Bombardier,et al.  Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. , 1994, The Journal of rheumatology.

[7]  J. Nossent,et al.  Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients. , 1993, Seminars in arthritis and rheumatism.

[8]  J. Carlin,et al.  Bias, prevalence and kappa. , 1993, Journal of clinical epidemiology.

[9]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[10]  C. Bombardier,et al.  Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. , 1992, The Journal of rheumatology.

[11]  M. Petri,et al.  Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. , 1991, Arthritis and rheumatism.

[12]  M. Liang,et al.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[13]  D. Symmons,et al.  Development and Assessment of a Computerized Index of Clinical Disease Activity in Systemic Lupus Erythematosus , 1988 .

[14]  M. Liang,et al.  Measurement of systemic lupus erythematosus activity in clinical research. , 1988, Arthritis and rheumatism.

[15]  R. Zwick,et al.  Another look at interrater agreement. , 1988, Psychological bulletin.

[16]  P. Schur,et al.  Serological and clinical remission in systemic lupus erythematosus. , 1985, The Journal of rheumatology.

[17]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[18]  D. Gladman,et al.  Prolonged complete remission in previously severe SLE. , 1982, Annals of the rheumatic diseases.

[19]  M. Ropes OBSERVATIONS ON THE NATURAL COURSE OF DISSEMINATED LUPUS ERYTHEMATOSUS , 1964, Medicine.

[20]  E. Dubois Systemic lupus erythematosus: recent advances in its diagnosis and treatment. , 1956, Annals of internal medicine.

[21]  P. Tumulty The clinical course of systemic lupus erythematosus. , 1954, Journal of the American Medical Association.

[22]  S. Gabriel,et al.  A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. , 1993, The Journal of rheumatology.

[23]  M. Petri,et al.  Validity and reliability of lupus activity measures in the routine clinic setting. , 1992, The Journal of rheumatology.

[24]  A. Feinstein,et al.  High agreement but low kappa: II. Resolving the paradoxes. , 1990, Journal of clinical epidemiology.